REGISTERED
on 28 Mar 2023
Last Applicant/ Owned by
2135 BEDELL ROAD, SUITE 9B
GRAND ISLAND
NY
14072
Serial Number
97167024 filed on 10th Dec 2021
Registration Number
7009804 registered on 28th Mar 2023
Correspondent Address
JOHN P. MURTAUGH
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
HYBRID CONCEPTS INTERNATIONAL
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative med Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases
First Use Date in General
31st Aug 2017
First Use Date in Commerce
31st Aug 2017
Class [042]
Computer & Software Services & Scientific Services
Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics
First Use Date in General
30th Jun 2017
First Use Date in Commerce
30th Jun 2017
Class [036]
Insurance & Financial Services
Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products
First Use Date in General
30th Jun 2017
First Use Date in Commerce
30th Jun 2017
Class [035]
Advertising, Business & Retail Services
Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations
First Use Date in General
30th Jun 2017
First Use Date in Commerce
30th Jun 2017
Mark Details
Serial Number
No 97167024
Mark Type
No Service Mark
Attorney Docket Number
No HYBR-65426
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
01.09.05 -
Atoms or molecular models
01.09.25 -
Other planets, asteroids, meteors
Legal History
| Status Date | Action Taken |
|---|---|
| 28th Mar 2023 | REGISTERED-PRINCIPAL REGISTER |
| 28th Mar 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 10th Jan 2023 | PUBLISHED FOR OPPOSITION |
| 10th Jan 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 21st Dec 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 02th Dec 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 01st Dec 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 30th Nov 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 30th Nov 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 17th Nov 2022 | NON-FINAL ACTION WRITTEN |